Gustave Roussy immune score is a prognostic marker in patients with small cell lung cancer undergoing immunotherapy: a real-world retrospective study

BACKGROUND: The utilization of the Gustave Roussy Immune Score (GRIm-Score) in patient selection for immunotherapy was initially reported. The objective of this retrospective study is to assess the potential of the GRIm-Score, a novel prognostic score based on nutritional and inflammatory markers, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Shangguan, Jian, Huang, Xinyi, Liu, Xu, Zhang, Zengfu, Zhang, Xiaodong, Yu, Jinming, Chen, Dawei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10187137/
https://www.ncbi.nlm.nih.gov/pubmed/37205200
http://dx.doi.org/10.3389/fonc.2023.1195499

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10187137/
https://www.ncbi.nlm.nih.gov/pubmed/37205200
http://dx.doi.org/10.3389/fonc.2023.1195499

Ejemplares similares